News | September 26, 2023
Briefs: Mankind Pharma and Sequent Scientific
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Currently, Praveen Akkinepally is the Head of Lung Cancer Commercialization, AstraZeneca Gaithersburg, MD, USA
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Subscribe To Our Newsletter & Stay Updated
